{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:14:09Z","timestamp":1790878449062,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004911","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Piau\u00ed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cbi.2022.110161","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T11:13:21Z","timestamp":1663240401000},"page":"110161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches"],"prefix":"10.1016","volume":"367","author":[{"given":"Esley S.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila C.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo S.A.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhyane C.","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz F.L.S.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyne R.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca B.M.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romulo O.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo M.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson A.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas A.D.","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-3382","authenticated-orcid":false,"given":"Jand V.R.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.110161_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"issue":"10223","key":"10.1016\/j.cbi.2022.110161_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cbi.2022.110161_bib3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.cbi.2022.110161_bib4","article-title":"Original: renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with covid","author":"Vaduganathan","year":"2020","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.cbi.2022.110161_bib5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.micinf.2013.08.003","article-title":"ACE2\u2013From the renin\u2013angiotensin system to gut microbiota and malnutrition","volume":"15","author":"Perlot","year":"2013","journal-title":"Microb. Infect."},{"issue":"8","key":"10.1016\/j.cbi.2022.110161_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/1087057111413919","article-title":"Prediction of off-target effects on angiotensin-converting enzyme 2","volume":"16","author":"Kulemina","year":"2011","journal-title":"J. Biomol. Screen"},{"issue":"8","key":"10.1016\/j.cbi.2022.110161_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/17512433.2020.1798760","article-title":"Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight","volume":"13","author":"Nicolau","year":"2020","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-020-01479-w","article-title":"From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses","volume":"21","author":"Zhu","year":"2020","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.cbi.2022.110161_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ibd\/izaa085","article-title":"Expression of SARS-CoV 2 entry molecules ACE2 and TMPRSS2 in the gut of patients with IBD","volume":"26","author":"Burgue\u00f1o","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-020-00652-6","article-title":"Structural models of human ACE2 variants with SARS-CoV 2 Spike protein for structure-based drug design","volume":"7","author":"Sorokina","year":"2020","journal-title":"Sci. Data"},{"key":"10.1016\/j.cbi.2022.110161_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107587","article-title":"Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients","volume":"213","author":"Liu","year":"2020","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.cbi.2022.110161_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.isci.2019.08.014","article-title":"Differential roles of cysteinyl cathepsins in TGF-\u03b2 signaling and tissue fibrosis","volume":"19","author":"Zhang","year":"2019","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.cbi.2022.110161_bib13","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV 2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.cbi.2022.110161_bib14","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/cancers11111736","article-title":"Adam17 activity and IL-6 trans-signaling in inflammation and cancer","volume":"11","author":"Schumacher","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cbi.2022.110161_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/0022-1317-83-3-595","article-title":"Conservation of substrate specificities among coronavirus main proteases","volume":"83","author":"Hegyi","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.cbi.2022.110161_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41589-020-00689-z","article-title":"SARS-CoV-2 M pro inhibitors and activity-based probes for patient-sample imaging","volume":"17","author":"Rut","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cbi.2022.110161_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV 2 main protease as drug target","author":"Ullrich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2022.110161_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109886","article-title":"What would S\u00e9rgio Ferreira say to your physician in this war against COVID-19: how about kallikrein\/kinin system?","volume":"143","author":"Nicolau","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"3","key":"10.1016\/j.cbi.2022.110161_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4102\/jsava.v76i3.416","article-title":"The pharmacokinetics of diminazene ceturate after intramuscular administration in healthy dogs","volume":"76","author":"Miller","year":"2005","journal-title":"J. South Afr. Vet. Assoc."},{"issue":"4","key":"10.1016\/j.cbi.2022.110161_bib20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.113.01337","article-title":"Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology","volume":"62","author":"Qi","year":"2013","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.cbi.2022.110161_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1164\/rccm.201205-0880OC","article-title":"Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models","volume":"187","author":"Shenoy","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.cbi.2022.110161_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048696","article-title":"Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection","volume":"7","author":"Kuriakose","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cbi.2022.110161_bib23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/1753425913507488","article-title":"Diminazene aceturate (Berenil) modulates LPS induced pro-inflammatory cytokine production by inhibiting phosphorylation of MAPKs and STAT proteins","volume":"20","author":"Kuriakose","year":"2014","journal-title":"Innate Immun."},{"key":"10.1016\/j.cbi.2022.110161_bib24","first-page":"9","article-title":"Anti-hypertensive effects of diminazene aceturate: an angiotensin- converting enzyme 2 activator in rats","volume":"23","author":"Marilda","year":"2016","journal-title":"Protein Pept. Lett."},{"issue":"5","key":"10.1016\/j.cbi.2022.110161_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2217\/fvl-2021-0160","article-title":"Can anti-parasitic drugs help control COVID-19?","volume":"17","author":"Panahi","year":"2022","journal-title":"Future Virol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.cbi.2022.110161_bib27","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5200","article-title":"Computational docking of biomolecular complexes with AutoDock","volume":"2009","author":"Goodsell","year":"2009","journal-title":"Cold Spring Harb. Protoc."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","article-title":"Automated docking of flexible ligands: applications of AutoDock","volume":"9","author":"Goodsell","year":"1996","journal-title":"J. Mol. Recogn."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib29","first-page":"8","article-title":"Using autodock for ligand\u2010receptor docking","volume":"24","author":"Morris","year":"2008","journal-title":"Curr. Protocols Bioinf."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib30","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"issue":"22","key":"10.1016\/j.cbi.2022.110161_bib31","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity\u2014a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"issue":"14","key":"10.1016\/j.cbi.2022.110161_bib32","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1287\/moor.6.1.19","article-title":"Minimization by random search techniques","volume":"6","author":"Solis","year":"1981","journal-title":"Math. Oper. Res."},{"issue":"6","key":"10.1016\/j.cbi.2022.110161_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198476","article-title":"Computational quantum chemistry, molecular docking, and ADMET predictions of imidazole alkaloids of Pilocarpus microphyllus with schistosomicidal properties","volume":"13","author":"Rocha","year":"2018","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.cbi.2022.110161_bib35","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jcc.20090","article-title":"A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force\u2010field parameter sets 53A5 and 53A6","volume":"25","author":"Oostenbrink","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2022.110161_bib36","author":"Abraham"},{"key":"10.1016\/j.cbi.2022.110161_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejmech.2017.08.019","article-title":"Structure-function studies of BPP-BrachyNH2 and synthetic analogues thereof with Angiotensin I-Converting Enzyme","volume":"139","author":"Arcanjo","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"W1","key":"10.1016\/j.cbi.2022.110161_bib38","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"suppl_2","key":"10.1016\/j.cbi.2022.110161_bib39","doi-asserted-by":"crossref","first-page":"W368","DOI":"10.1093\/nar\/gki464","article-title":"H++: a server for estimating p K as and adding missing hydrogens to macromolecules","volume":"33","author":"Gordon","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.cbi.2022.110161_bib40","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1021\/acs.jctc.8b00768","article-title":"Automated topology builder version 3.0: prediction of solvation free enthalpies in water and hexane","volume":"14","author":"Stroet","year":"2018","journal-title":"J. Chem. Theor. Comput."},{"issue":"10","key":"10.1016\/j.cbi.2022.110161_bib41","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"10.1016\/j.cbi.2022.110161_bib42","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1007\/s00894-012-1383-6","article-title":"Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Mycobacterium tuberculosis with isoniazid: a computational study on a new possible mechanism of resistance","volume":"18","author":"Ramos","year":"2012","journal-title":"J. Mol. Model."},{"issue":"7","key":"10.1016\/j.cbi.2022.110161_bib43","first-page":"4016","article-title":"SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options","volume":"24","author":"Chakraborty","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2022.110161_bib44","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3389\/fmicb.2020.01796","article-title":"Quinolines-based SARS-CoV 2 3CLpro and RdRp inhibitors and Spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: na in silico analysis","volume":"11","author":"Alexpandi","year":"2020","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.cbi.2022.110161_bib45","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV 2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.cbi.2022.110161_bib47","doi-asserted-by":"crossref","first-page":"e2000028","DOI":"10.1002\/minf.202000028","article-title":"Rapid identification of potential inhibitors of SARS\u2010CoV\u20102 main protease by deep docking of 1.3 billion compounds","volume":"39","author":"Ton","year":"2022","journal-title":"Mol. Inf."},{"issue":"3","key":"10.1016\/j.cbi.2022.110161_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0035-9203(62)90158-X","article-title":"Berenil in the treatment of Trypanosoma gambiense infection in man","volume":"56","author":"Hutchinson","year":"1962","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.cbi.2022.110161_bib49","first-page":"148","article-title":"Retrospective long-term study of effects of berenil by follow-up of patients treated since 1965","volume":"35","author":"Abaru","year":"1984","journal-title":"Tropenmed. Parasitol."},{"issue":"4","key":"10.1016\/j.cbi.2022.110161_bib50","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cbi.2022.110161_bib51","first-page":"1653","article-title":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe","volume":"382","author":"Diaz","year":"2020","journal-title":"J. Trav. Med."},{"issue":"9","key":"10.1016\/j.cbi.2022.110161_bib52","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41401-020-0430-6","article-title":"Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication","volume":"41","author":"Pang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.cbi.2022.110161_bib53","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jmv.25992","article-title":"ACE2 activators for the treatment of COVID 19 patients","volume":"92","author":"Rodr\u00edguez\u2010Puertas","year":"2020","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.cbi.2022.110161_bib54","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/biom10060954","article-title":"Class AG protein-coupled receptor antagonist famotidine as a therapeutic alternative against SARS-CoV 2: an in silico analysis","volume":"10","author":"Ortega","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.cbi.2022.110161_bib55","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/biomedicines10071731","article-title":"Diminazene aceturate reduces angiotensin II constriction and interacts with the spike protein of severe acute respiratory syndrome coronavirus 2","volume":"10","author":"Matsoukas","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cbi.2022.110161_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1501240","article-title":"Regulation of protein-ligand binding affinity by hydrogen bond pairing","volume":"2","author":"Chen","year":"2016","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.cbi.2022.110161_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221331","article-title":"Identification of lead molecules against potential drug target protein MAPK4 from L. donovani: an in-silico approach using docking, molecular dynamics and binding free energy calculation","volume":"14","author":"Raj","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.110161_bib58","first-page":"319","article-title":"Screening of preferential binding affinity of selected natural compounds to SARS-CoV 2 proteins using in silico methods","volume":"4","author":"Tomic","year":"2020","journal-title":"EJMO"},{"issue":"7811","key":"10.1016\/j.cbi.2022.110161_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M pro from SARS-CoV 2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cbi.2022.110161_bib60","doi-asserted-by":"crossref","DOI":"10.1063\/5.0013029","article-title":"Topological analysis of SARS-CoV 2 main protease","volume":"30","author":"Estrada","year":"2020","journal-title":"Chaos: Interdiscip. J. Nonlinear Sci."},{"key":"10.1016\/j.cbi.2022.110161_bib61","first-page":"1","article-title":"Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies","author":"Chikhale","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.cbi.2022.110161_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1764868","article-title":"Prevention of SARS-CoV 2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2","author":"Gyebi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.cbi.2022.110161_bib63","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV 2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cbi.2022.110161_bib64","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.cbi.2022.110161_bib65","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ndt\/gfaa093","article-title":"ADAM17 inhibition may exert a protective effect on COVID-19","volume":"35","author":"Palau","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00044-014-1097-7","article-title":"Virtual screening-based identification of lead molecules as selective TACE inhibitors","volume":"24","author":"Murumkar","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.cbi.2022.110161_bib67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jmgm.2016.10.003","article-title":"In silico approaches and proportional odds model towards identifying selective adam17 inhibitors from anti-inflammatory natural molecules","volume":"70","author":"Borah","year":"2016","journal-title":"J. Mol. Graph. Model."},{"issue":"3","key":"10.1016\/j.cbi.2022.110161_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106119","article-title":"In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV 2 infection","volume":"56","author":"Braz","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"10.1016\/j.cbi.2022.110161_bib69","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jmv.25726","article-title":"Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS\u2010CoV\u20102","volume":"92","author":"Liu","year":"2020","journal-title":"J. Med. Virol."},{"issue":"17","key":"10.1016\/j.cbi.2022.110161_bib70","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.3390\/molecules25173822","article-title":"In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection","volume":"25","author":"Vivek-Ananth","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib71","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/anie.201006781","article-title":"Systematic investigation of halogen bonding in protein\u2013ligand interactions","volume":"50","author":"Hardegger","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.cbi.2022.110161_bib72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2022.110161_bib73","series-title":"Compilation of Potential Protein Targets for SARS-CoV 2: Preparation of Homology Model and Active Site Determination for Future Rational Antiviral Design","author":"Pal","year":"2020"},{"issue":"7047","key":"10.1016\/j.cbi.2022.110161_bib74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.110161_bib75","first-page":"1","article-title":"The role of IL-6 and IL-6 blockade in COVID-19","author":"Potere","year":"2021","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.cbi.2022.110161_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119264","article-title":"Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis","volume":"10","author":"Mart\u00ednez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.110161_bib77","series-title":"Characterization of Spike Glycoprotein of 2019-nCoV on Virus Entry and its Immune Cross-Reactivity with Spike Glycoprotein of SARS-CoV","author":"Ou","year":"2020"},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245258","article-title":"Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)","volume":"16","author":"Egieyeh","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-00192-8","article-title":"Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro","volume":"6","author":"Kwon","year":"2020","journal-title":"Cell Discov."},{"issue":"1","key":"10.1016\/j.cbi.2022.110161_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-84850-1","article-title":"Polyunsaturated \u03c9-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry","volume":"11","author":"Goc","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2022.110161_bib81","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3389\/fchem.2020.572885","article-title":"Hijacking SARS-CoV-2\/ACE2 receptor interaction by natural and semi-synthetic steroidal agents acting on functional pockets on the receptor binding domain","volume":"8","author":"Carino","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.cbi.2022.110161_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114215","article-title":"The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations","volume":"182","author":"Neufurth","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"26","key":"10.1016\/j.cbi.2022.110161_bib83","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1039\/D0CC08387A","article-title":"Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides","volume":"57","author":"Maas","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.cbi.2022.110161_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.cbi.2022.110161_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.crchbi.2022.100023","article-title":"Discovery of diminazene as a dual inhibitor of SARS-CoV-2 human host proteases TMPRSS2 and furin using cell-based assays","volume":"2","author":"Xu","year":"2022","journal-title":"Curr. Res. Chem. Biol."},{"key":"10.1016\/j.cbi.2022.110161_bib86","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.phrs.2015.10.005","article-title":"Diminazene aceturate\u2014an antiparasitic drug of antiquity: advances in pharmacology & therapeutics","volume":"102","author":"Oliveira","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"3\u20134","key":"10.1016\/j.cbi.2022.110161_bib87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0001-706X(93)90092-P","article-title":"Pharmacology of diminazene: a review","volume":"54","author":"Peregrine","year":"1993","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.cbi.2022.110161_bib88","first-page":"1032","article-title":"Diminazene aceturate is an ACE2 activator and a novel antihypertensive drug","volume":"24","author":"Gjymishka","year":"2010","journal-title":"Faseb. J."},{"issue":"4","key":"10.1016\/j.cbi.2022.110161_bib89","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/fmb-2021-0018","article-title":"Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment","volume":"16","author":"Kate gadanec","year":"2021","journal-title":"Future Microbiol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722003660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722003660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:10:56Z","timestamp":1757859056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722003660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":89,"alternative-id":["S0009279722003660"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110161","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110161"}}